Cargando…
Comparison of humoral and cellular immune responses in hematologic diseases following completed vaccination protocol with BBIBP-CorV, or AZD1222, or BNT162b2 vaccines against SARS-CoV-2
BACKGROUND: Vaccination has proven the potential to control the COVID-19 pandemic worldwide. Although recent evidence suggests a poor humoral response against SARS-CoV-2 in vaccinated hematological disease (HD) patients, data on vaccination in these patients is limited with the comparison of mRNA-ba...
Autores principales: | Szabó, Enikő, Modok, Szabolcs, Rónaszéki, Benedek, Faragó, Anna, Gémes, Nikolett, Nagy, Lajos I., Hackler, László, Farkas, Katalin, Neuperger, Patrícia, Balog, József Á., Balog, Attila, Puskás, László G., Szebeni, Gabor J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389666/ https://www.ncbi.nlm.nih.gov/pubmed/37529238 http://dx.doi.org/10.3389/fmed.2023.1176168 |
Ejemplares similares
-
Comparison of Homologous and Heterologous Booster SARS-CoV-2 Vaccination in Autoimmune Rheumatic and Musculoskeletal Patients
por: Honfi, Dániel, et al.
Publicado: (2022) -
Persistence of immune responses to the Sinopharm/BBIBP‐CorV vaccine
por: Jeewandara, Chandima, et al.
Publicado: (2022) -
Humoral and Cellular Immunogenicity and Safety of Five Different SARS-CoV-2 Vaccines in Patients With Autoimmune Rheumatic and Musculoskeletal Diseases in Remission or With Low Disease Activity and in Healthy Controls: A Single Center Study
por: Szebeni, Gábor J., et al.
Publicado: (2022) -
BBIBP-CorV: Hepatitis: case report
Publicado: (2022) -
Introduction of an Ultraviolet C-Irradiated 4T1 Murine Breast Cancer Whole-Cell Vaccine Model
por: Szebeni, Gábor J., et al.
Publicado: (2023)